Pompe Disease Market By Therapy Type, Molecule Type, Route of Administration and Dosage Forms- Global Industry Analysis & Forecast to 2027
Published On : December 2018 Pages : 130 Category: Pharma & Healthcare Report Code : HC122123
Pompe Disease Market By Therapy Type (Substrate Reduction Therapy, Enzyme Replacement Therapy) Molecule Type (Small Molecules, Biologics) Route of Administration (Parenteral, Oral) and Dosage Forms (Liquid, Solid) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Pompe Disease Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Pompe disease is a turmoil caused by the development of a perplexing sugar known as glycogen in the body's cells. It is hereditarily acquired and the aggregation of glycogen in specific organs and additionally tissues, particularly muscles, impedes their capacity to work regularly. Pompe diseases influences around one individual in 40,000 in the U.S.; nonetheless, the occurrence changes among various ethnic groups.
Drivers and Restraints
Expanding research exercises preformed to locate a powerful treatment for the sickness and the development in the exceptional administrative medication assignments for vagrant medications drive the market. Nonetheless, swelled expenses related with the Pompe infection treatment control the market development. Moreover, rising immunotherapeutic methodologies for Pompe disease provides rewarding opportunities for the development of the market.
Regional Insights
Geographically, North America is one of the dominating markets and this trend is anticipated to continue in future.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- BioMarin Pharmaceutical
- Genzyme
- EpiVax
- Sangamo BioSciences
- Amicus Therapeutics
- Audentes Therapeutics
- Oxyrane
- Valerion Therapeutics
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Pompe Disease Market, By Therapy Type, Estimates and Forecast, 2017-2027 ($Million)
· Substrate Reduction Therapy
· Enzyme Replacement Therapy
· Pompe Disease Market, By Molecule Type, Estimates and Forecast, 2017-2027 ($Million)
· Small Molecules
· Biologics
· Pompe Disease Market, By Route of Administration, Estimates and Forecast, 2017-2027 ($Million)
· Parenteral
· Oral
· Pompe Disease Market, By Dosage Forms, Estimates and Forecast, 2017-2027 ($Million)
· Liquid
· Solid
· Pompe Disease Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Pompe Disease Market, By Country
o U.S. Pompe Disease Market
o Canada Pompe Disease Market
o Mexico Pompe Disease Market
o Europe
§ Europe Pompe Disease Market, By Country
o Germany Pompe Disease Market
o UK Pompe Disease Market
o France Pompe Disease Market
o Russia Pompe Disease Market
o Italy Pompe Disease Market
o Rest of Europe Pompe Disease Market
o Asia-Pacific
§ Asia-Pacific Pompe Disease Market, By Country
o China Pompe Disease Market
o Japan Pompe Disease Market
o South Korea Pompe Disease Market
o India Pompe Disease Market
o Southeast Asia Pompe Disease Market
o Rest of Asia-Pacific Pompe Disease Market
o South America
§ South America Pompe Disease Market
o Brazil Pompe Disease Market
o Argentina Pompe Disease Market
o Columbia Pompe Disease Market
o Rest of South America Pompe Disease Market
o Middle East and Africa
§ Middle East and Africa Pompe Disease Market
o Saudi Arabia Pompe Disease Market
o UAE Pompe Disease Market
o Egypt Pompe Disease Market
o Nigeria Pompe Disease Market
o South Africa Pompe Disease Market
o Rest of MEA Pompe Disease Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Pompe Disease Market, By Therapy Type
5.1. Introduction
5.2. Global Pompe Disease Revenue and Market Share by Therapy Type (2017-2027)
5.2.1. Global Pompe Disease Revenue and Revenue Share by Therapy Type (2017-2027)
5.3. Substrate Reduction Therapy
5.3.1. Global Substrate Reduction Therapy Revenue and Growth Rate (2017-2027)
5.4. Enzyme Replacement Therapy
5.4.1. Global Enzyme Replacement Therapy Revenue and Growth Rate (2017-2027)
6. Pompe Disease Market, By Molecule Type
6.1. Introduction
6.2. Global Pompe Disease Revenue and Market Share by Molecule Type (2017-2027)
6.2.1. Global Pompe Disease Revenue and Revenue Share by Molecule Type (2017-2027)
6.3. Small Molecules
6.3.1. Global Small Molecules Revenue and Growth Rate (2017-2027)
6.4. Biologics
6.4.1. Global Biologics Revenue and Growth Rate (2017-2027)
7. Pompe Disease Market, By Route Of Administration
7.1. Introduction
7.2. Global Pompe Disease Revenue and Market Share by Route Of Administration (2017-2027)
7.2.1. Global Pompe Disease Revenue and Revenue Share by Route Of Administration (2017-2027)
7.3. Parenteral
7.3.1. Global Parenteral Revenue and Growth Rate (2017-2027)
7.4. Oral
7.4.1. Global Oral Revenue and Growth Rate (2017-2027)
8. Pompe Disease Market, By Dosage Forms
8.1. Introduction
8.2. Global Pompe Disease Revenue and Market Share by Dosage Forms (2017-2027)
8.2.1. Global Pompe Disease Revenue and Revenue Share by Dosage Forms (2017-2027)
8.3. Liquid
8.3.1. Global Liquid Revenue and Growth Rate (2017-2027)
8.4. Solid
8.4.1. Global Solid Revenue and Growth Rate (2017-2027)
9. Pompe Disease Market, By Region
9.1. Introduction
9.2. Global Pompe Disease Revenue and Market Share by Regions
9.2.1. Global Pompe Disease Revenue by Regions (2017-2027)
9.3. North America Pompe Disease by Countries
9.3.1. North America Pompe Disease Revenue and Growth Rate (2017-2027)
9.3.2. North America Pompe Disease Revenue (Million USD) by Countries (2017-2027)
9.3.3. United States
9.3.3.1. United States Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.3.4. Canada
9.3.4.1. Canada Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.3.5. Mexico
9.3.5.1. Mexico Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.4. Europe Pompe Disease by Countries
9.4.1. Europe Pompe Disease Revenue and Growth Rate (2017-2027)
9.4.2. Europe Pompe Disease Revenue (Million USD) by Countries (2017-2027)
9.4.3. Germany
9.4.3.1. Germany Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.4. France
9.4.4.1. France Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.5. UK
9.4.5.1. UK Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.6. Russia
9.4.6.1. Russia Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.7. Italy
9.4.7.1. Italy Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.4.8. Rest of Europe
9.4.8.1. Rest of Europe Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.5. Asia-Pacific Pompe Disease by Countries
9.5.1. Asia-Pacific Pompe Disease Revenue and Growth Rate (2017-2027)
9.5.2. Asia-Pacific Pompe Disease Revenue (Million USD) by Countries (2017-2027)
9.5.3. China
9.5.3.1. China Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.4. Japan
9.5.4.1. Japan Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.5. Korea
9.5.5.1. Korea Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.6. India
9.5.6.1. India Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.7. Southeast Asia
9.5.7.1. Southeast Asia Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.5.8. Rest of Asia-Pacific
9.5.8.1. Rest of Asia-Pacific Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.6. South America Pompe Disease by Countries
9.6.1. South America Pompe Disease Revenue and Growth Rate (2017-2027)
9.6.2. South America Pompe Disease Revenue (Million USD) by Countries (2017-2027)
9.6.3. Brazil
9.6.3.1. Brazil Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.4. Argentina
9.6.4.1. Argentina Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.5. Columbia
9.6.5.1. Columbia Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.6.6. Rest of South America
9.6.6.1. Rest of South America Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.7. Middle East and Africa Pompe Disease by Countries
9.7.1. Middle East and Africa Pompe Disease Revenue and Growth Rate (2017-2027)
9.7.2. Middle East and Africa Pompe Disease Revenue (Million USD) by Countries (2017-2027)
9.7.3. Saudi Arabia
9.7.3.1. Saudi Arabia Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.4. United Arab Emirates
9.7.4.1. United Arab Emirates Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.5. Egypt
9.7.5.1. Egypt Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.6. Nigeria
9.7.6.1. Nigeria Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.7. South Africa
9.7.7.1. South Africa Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.8. Turkey
9.7.8.1. Turkey Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
9.7.9. Rest of Middle East and Africa
9.7.9.1. Rest of Middle East and Africa Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
10. Company Profiles
10.1. BioMarin Pharmaceutical
10.1.1. Business Overview
10.1.2. Service Portfolio
10.1.3. Strategic Developments
10.1.4. Revenue and Market Share
10.2. Genzyme
10.2.1. Business Overview
10.2.2. Service Portfolio
10.2.3. Strategic Developments
10.2.4. Revenue and Market Share
10.3. EpiVax
10.3.1. Business Overview
10.3.2. Service Portfolio
10.3.3. Strategic Developments
10.3.4. Revenue and Market Share
10.4. Sangamo BioSciences
10.4.1. Business Overview
10.4.2. Service Portfolio
10.4.3. Strategic Developments
10.4.4. Revenue and Market Share
10.5. Amicus Therapeutics
10.5.1. Business Overview
10.5.2. Service Portfolio
10.5.3. Strategic Developments
10.5.4. Revenue and Market Share
10.6. Audentes Therapeutics
10.6.1. Business Overview
10.6.2. Service Portfolio
10.6.3. Strategic Developments
10.6.4. Revenue and Market Share
10.7. Oxyrane
10.7.1. Business Overview
10.7.2. Service Portfolio
10.7.3. Strategic Developments
10.7.4. Revenue and Market Share
10.8. Valerion Therapeutics
10.8.1. Business Overview
10.8.2. Service Portfolio
10.8.3. Strategic Developments
10.8.4. Revenue and Market Share
11. Global Pompe Disease Market Competition, by Manufacturer
11.1. Global Pompe Disease Revenue and Market Share by Manufacturer (2017-2017)
11.2. Global Pompe Disease Price By Region (2017-2017)
11.3. Top 5 Pompe Disease Manufacturer Market Share
11.4. Market Competition Trend
12. Pompe Disease Market Forecast (2017-2027)
12.1. Global Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2027)
12.2. Pompe Disease Market Forecast by Regions (2017-2027)
12.2.1. North America Pompe Disease Market Forecast (2017-2027)
12.2.1.1. United States Pompe Disease Market Forecast (2017-2027)
12.2.1.2. Canada Pompe Disease Market Forecast (2017-2027)
12.2.1.3. Mexico Pompe Disease Market Forecast (2017-2027)
12.2.2. Europe Pompe Disease Market Forecast (2017-2027)
12.2.2.1. Germany Pompe Disease Market Forecast (2017-2027)
12.2.2.2. France Pompe Disease Market Forecast (2017-2027)
12.2.2.3. UK Pompe Disease Market Forecast (2017-2027)
12.2.2.4. Russia Pompe Disease Market Forecast (2017-2027)
12.2.2.5. Italy Pompe Disease Market Forecast (2017-2027)
12.2.2.6. Rest of Europe Pompe Disease Market Forecast (2017-2027)
12.2.3. Asia-Pacific Pompe Disease Market Forecast (2017-2027)
12.2.3.1. China Pompe Disease Market Forecast (2017-2027)
12.2.3.2. Japan Pompe Disease Market Forecast (2017-2027)
12.2.3.3. Korea Pompe Disease Market Forecast (2017-2027)
12.2.3.4. India Pompe Disease Market Forecast (2017-2027)
12.2.3.5. Southeast Asia Pompe Disease Market Forecast (2017-2027)
12.2.3.6. Rest of Asia-Pacific Pompe Disease Market Forecast (2017-2027)
12.2.4. South America Pompe Disease Market Forecast (2017-2027)
12.2.4.1. Brazil Pompe Disease Market Forecast (2017-2027)
12.2.4.2. Argentina Pompe Disease Market Forecast (2017-2027)
12.2.4.3. Columbia Pompe Disease Market Forecast (2017-2027)
12.2.4.4. Rest of South America Pompe Disease Market Forecast (2017-2027)
12.2.5. Middle East and Africa Pompe Disease Market Forecast (2017-2027)
12.2.5.1. Saudi Arabia Pompe Disease Market Forecast (2017-2027)
12.2.5.2. United Arab Emirates Pompe Disease Market Forecast (2017-2027)
12.2.5.3. Egypt Pompe Disease Market Forecast (2017-2027)
12.2.5.4. Nigeria Pompe Disease Market Forecast (2017-2027)
12.2.5.5. South Africa Pompe Disease Market Forecast (2017-2027)
12.2.5.6. Turkey Pompe Disease Market Forecast (2017-2027)
12.2.5.7. Rest of Middle East and Africa Pompe Disease Market Forecast (2017-2027)
12.3. Pompe Disease Market Forecast by Therapy Type (2017-2027)
12.3.1. Pompe Disease Forecast by Therapy Type (2017-2027)
12.3.2. Pompe Disease Market Share Forecast by Therapy Type (2017-2027)
12.4. Pompe Disease Market Forecast by Molecule Type (2017-2027)
12.4.1. Pompe Disease Forecast by Molecule Type (2017-2027)
12.4.2. Pompe Disease Market Share Forecast by Molecule Type (2017-2027)
12.5. Pompe Disease Market Forecast by Route Of Administration (2017-2027)
12.5.1. Pompe Disease Forecast by Route Of Administration (2017-2027)
12.5.2. Pompe Disease Market Share Forecast by Route Of Administration (2017-2027)
12.6. Pompe Disease Market Forecast by Dosage Forms (2017-2027)
12.6.1. Pompe Disease Forecast by Dosage Forms (2017-2027)
12.6.2. Pompe Disease Market Share Forecast by Dosage Forms (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Pompe Disease Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Pompe Disease Revenue and Revenue Share by Therapy Type (2017-2018)
Figure Global Substrate Reduction Therapy Revenue and Growth Rate (2017-2018)
Figure Global Enzyme Replacement Therapy Revenue and Growth Rate (2017-2018)
Table Global Pompe Disease Revenue and Revenue Share by Molecule Type (2017-2018)
Figure Global Small Molecules Revenue and Growth Rate (2017-2018)
Figure Global Biologics Revenue and Growth Rate (2017-2018)
Table Global Pompe Disease Revenue and Revenue Share by Route Of Administration (2017-2018)
Figure Global Parenteral Revenue and Growth Rate (2017-2018)
Figure Global Oral Revenue and Growth Rate (2017-2018)
Table Global Pompe Disease Revenue and Revenue Share by Dosage Forms (2017-2018)
Figure Global Liquid Revenue and Growth Rate (2017-2018)
Figure Global Solid Revenue and Growth Rate (2017-2018)
Table Global Pompe Disease Revenue by Regions (2017-2018)
Figure North America Pompe Disease Growth Rate (2017-2018)
Figure North America Pompe Disease Revenue and Growth Rate (2017-2018)
Figure North America Pompe Disease by Countries (2017-2018)
Figure North America Pompe Disease Revenue (Million USD) by Countries (2017-2018)
Figure United States Pompe Disease Growth Rate (2017-2018)
Figure United States Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Pompe Disease Growth Rate (2017-2018)
Figure Canada Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Pompe Disease Growth Rate (2017-2018)
Figure Mexico Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Pompe Disease Growth Rate (2017-2018)
Figure Europe Pompe Disease Revenue and Growth Rate (2017-2018)
Figure Europe Pompe Disease by Countries (2017-2018)
Figure Europe Pompe Disease Revenue (Million USD) by Countries (2017-2018)
Figure Germany Pompe Disease Growth Rate (2017-2018)
Figure Germany Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Pompe Disease Growth Rate (2017-2018)
Figure France Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Pompe Disease Growth Rate (2017-2018)
Figure UK Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Pompe Disease Growth Rate (2017-2018)
Figure Russia Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Pompe Disease Growth Rate (2017-2018)
Figure Italy Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Pompe Disease Growth Rate (2017-2018)
Figure Rest of Europe Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Pompe Disease Growth Rate (2017-2018)
Figure Asia-Pacific Pompe Disease Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Pompe Disease by Countries (2017-2018)
Figure Asia-Pacific Pompe Disease Revenue (Million USD) by Countries (2017-2018)
Figure China Pompe Disease Growth Rate (2017-2018)
Figure China Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Pompe Disease Growth Rate (2017-2018)
Figure Japan Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Pompe Disease Growth Rate (2017-2018)
Figure Korea Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Pompe Disease Growth Rate (2017-2018)
Figure India Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Pompe Disease Growth Rate (2017-2018)
Figure Southeast Asia Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pompe Disease Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Pompe Disease Growth Rate (2017-2018)
Figure South America Pompe Disease Revenue and Growth Rate (2017-2018)
Figure South America Pompe Disease by Countries (2017-2018)
Figure South America Pompe Disease Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Pompe Disease Growth Rate (2017-2018)
Figure Brazil Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Pompe Disease Growth Rate (2017-2018)
Figure Argentina Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Pompe Disease Growth Rate (2017-2018)
Figure Columbia Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Pompe Disease Growth Rate (2017-2018)
Figure Rest of South America Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Pompe Disease Growth Rate (2017-2018)
Figure Middle East and Africa Pompe Disease Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Pompe Disease by Countries (2017-2018)
Figure Middle East and Africa Pompe Disease Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Pompe Disease Growth Rate (2017-2018)
Figure Saudi Arabia Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Pompe Disease Growth Rate (2017-2018)
Figure United Arab Emirates Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Pompe Disease Growth Rate (2017-2018)
Figure Egypt Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Pompe Disease Growth Rate (2017-2018)
Figure Nigeria Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Pompe Disease Growth Rate (2017-2018)
Figure South Africa Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Pompe Disease Growth Rate (2017-2018)
Figure Turkey Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pompe Disease Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pompe Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Table BioMarin Pharmaceutical Pompe Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Genzyme Pompe Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table EpiVax Pompe Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sangamo BioSciences Pompe Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Amicus Therapeutics Pompe Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Audentes Therapeutics Pompe Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Oxyrane Pompe Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Valerion Therapeutics Pompe Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Pompe Disease Market Share by Manufacturer
Figure Global Pompe Disease Revenue and Market Share by Manufacturer
Table Global Pompe Disease Price by Region (2017-2017)
Figure Top 5 Pompe Disease Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Pompe Disease Revenue (Millions USD) and Growth Rate (2018-2025)
Table Pompe Disease Market Forecast by Regions (2018-2025)
Figure North America Pompe Disease Market Forecast (2018-2025)
Figure United States Pompe Disease Market Forecast (2018-2025)
Figure Canada Pompe Disease Market Forecast (2018-2025)
Figure Mexico Pompe Disease Market Forecast (2018-2025)
Figure Europe Pompe Disease Market Forecast (2018-2025)
Figure Germany Pompe Disease Market Forecast (2018-2025)
Figure France Pompe Disease Market Forecast (2018-2025)
Figure UK Pompe Disease Market Forecast (2018-2025)
Figure Russia Pompe Disease Market Forecast (2018-2025)
Figure Italy Pompe Disease Market Forecast (2018-2025)
Figure Rest of Europe Pompe Disease Market Forecast (2018-2025)
Figure Asia-Pacific Pompe Disease Market Forecast (2018-2025)
Figure China Pompe Disease Market Forecast (2018-2025)
Figure Japan Pompe Disease Market Forecast (2018-2025)
Figure Korea Pompe Disease Market Forecast (2018-2025)
Figure India Pompe Disease Market Forecast (2018-2025)
Figure Southeast Asia Pompe Disease Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Pompe Disease Market Forecast (2018-2025)
Figure South America Pompe Disease Market Forecast (2018-2025)
Figure Brazil Pompe Disease Market Forecast (2018-2025)
Figure Argentina Pompe Disease Market Forecast (2018-2025)
Figure Columbia Pompe Disease Market Forecast (2018-2025)
Figure Rest of South America Pompe Disease Market Forecast (2018-2025)
Figure Middle East and Africa Pompe Disease Market Forecast (2018-2025)
Figure Saudi Arabia Pompe Disease Market Forecast (2018-2025)
Figure United Arab Emirates Pompe Disease Market Forecast (2018-2025)
Figure Egypt Pompe Disease Market Forecast (2018-2025)
Figure Nigeria Pompe Disease Market Forecast (2018-2025)
Figure South Africa Pompe Disease Market Forecast (2018-2025)
Figure Turkey Pompe Disease Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Pompe Disease Market Forecast (2018-2025)
Figure Global Pompe Disease Forecast by Therapy Type (2018-2025)
Figure Global Pompe Disease Market Share Forecast by Therapy Type (2018-2025)
Figure Global Pompe Disease Forecast by Therapy Type (2018-2025)
Figure Global Pompe Disease Forecast by Molecule Type (2018-2025)
Figure Global Pompe Disease Market Share Forecast by Molecule Type (2018-2025)
Figure Global Pompe Disease Forecast by Molecule Type (2018-2025)
Figure Global Pompe Disease Forecast by Route Of Administration (2018-2025)
Figure Global Pompe Disease Market Share Forecast by Route Of Administration (2018-2025)
Figure Global Pompe Disease Forecast by Route Of Administration (2018-2025)
Figure Global Pompe Disease Forecast by Dosage Forms (2018-2025)
Figure Global Pompe Disease Market Share Forecast by Dosage Forms (2018-2025)
Figure Global Pompe Disease Forecast by Dosage Forms (2018-2025).
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|